Therapy Areas: Devices
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
24 August 2026 - Medical technology company Tempus AI Inc (NASDAQ: TEM) reported on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-ena...
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
24 August 2026 - Medical technology company Pulnovo Medical announced on Sunday the enrolment of the first two patients in its PULSE-LHD clinical trial, conducted under a US Food and Drug Administrati...
Implantica's RefluxStop receives US FDA approval
21 August 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Premark...
Sectra to provide Education Portal to Loyalist College for medical imaging training
19 August 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it will provide its cloud-based Education Portal to Loyalist College in Ontario, Cana...
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
19 August 2026 - Aqua Medical Inc, a clinical-stage medical technology company advancing Endoscopic Metabolic Restoration, announced on Tuesday the treatment of the first West Coast patient (second ov...
Abbott and NACHC launch nationwide Food for Health initiative
18 August 2026 - American multinational medical devices and health care company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced on Monday a multi-year �...